These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21779486)

  • 1. Epigenetic Silencing of ALDH1L1, a Metabolic Regulator of Cellular Proliferation, in Cancers.
    Oleinik NV; Krupenko NI; Krupenko SA
    Genes Cancer; 2011 Feb; 2(2):130-9. PubMed ID: 21779486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Sequencing Revealed a CpG Methylation Pattern Associated With
    Beniaminov AD; Puzanov GA; Krasnov GS; Kaluzhny DN; Kazubskaya TP; Braga EA; Kudryavtseva AV; Melnikova NV; Dmitriev AA
    Front Genet; 2018; 9():169. PubMed ID: 29868117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploratory Metabolomics Underscores the Folate Enzyme ALDH1L1 as a Regulator of Glycine and Methylation Reactions.
    Rushing BR; Fogle HM; Sharma J; You M; McCormac JP; Molina S; Sumner S; Krupenko NI; Krupenko SA
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHIP E3 ligase mediates proteasomal degradation of the proliferation regulatory protein ALDH1L1 during the transition of NIH3T3 fibroblasts from G0/G1 to S-phase.
    Khan QA; Pediaditakis P; Malakhau Y; Esmaeilniakooshkghazi A; Ashkavand Z; Sereda V; Krupenko NI; Krupenko SA
    PLoS One; 2018; 13(7):e0199699. PubMed ID: 29979702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression.
    Krupenko SA; Krupenko NI
    Chem Biol Interact; 2019 Apr; 302():149-155. PubMed ID: 30794800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALDH1L1 and ALDH1L2 Folate Regulatory Enzymes in Cancer.
    Krupenko SA; Krupenko NI
    Adv Exp Med Biol; 2018; 1032():127-143. PubMed ID: 30362096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
    Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
    Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual promoter regulation of death-associated protein kinase gene leads to differentially silenced transcripts by methylation in cancer.
    Pulling LC; Grimes MJ; Damiani LA; Juri DE; Do K; Tellez CS; Belinsky SA
    Carcinogenesis; 2009 Dec; 30(12):2023-30. PubMed ID: 19917631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
    Manjegowda MC; Gupta PS; Limaye AM
    Gene; 2017 May; 614():65-73. PubMed ID: 28286086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation of a non-CpG island promoter represses NQO1 expression in rat arsenic-transformed lung epithelial cells.
    Huang N; Pei X; Lin W; Chiu JF; Tao T; Li G
    Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):733-739. PubMed ID: 29889218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
    Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
    Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of human cancer/testis antigen gene, XAGE-1, in tumor cells is correlated with CpG island hypomethylation.
    Lim JH; Kim SP; Gabrielson E; Park YB; Park JW; Kwon TK
    Int J Cancer; 2005 Aug; 116(2):200-6. PubMed ID: 15800911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of CpG island methylation status in O6-methylguanine-DNA methyltransferase expression of oral cancer cell lines.
    Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Nagatsuka H; Kokeguchi S; Inoue T; Kawasaki S; Tanaka N; MacPhee D; Matsubara N; Kishi K
    Oncol Rep; 2004 Aug; 12(2):339-45. PubMed ID: 15254699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
    Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
    Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation of the specific CpG island portion regulates cyclooxygenase-2 gene expression in human gastric carcinomas.
    Hur K; Song SH; Lee HS; Ho Kim W; Bang YJ; Yang HK
    Biochem Biophys Res Commun; 2003 Oct; 310(3):844-51. PubMed ID: 14550281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
    Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
    Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.